Drug-concentration versus symptom-driven dose adaptation of Infliximab in patients with active Crohn's disease: a prospective, randomised, multicentre trial (Tailorix)

G. D’Haens, Séverine Vermeire, Guy Lambrecht, F Baert, Peter Bossuyt, Maria Nachury, Anthony Buisson, Yoram Bouhnik, Jérôme Filippi, J Vande Woude,

2016 · 25 citations · 0 references

Concepts